43
Views
13
CrossRef citations to date
0
Altmetric
Review

Nucleoside transporter proteins: emerging targets for drug discovery

, , , &
Pages 515-539 | Published online: 25 Feb 2005

Bibliography

  • CASS CE, YOUNG JD, BALDWIN SA et al.: Nucleoside transporters of mammalian cells. In: Membrane Transporters as Drug Targets. Amidon GL, Sadee W (Eds.), Kluwer Academic/Plenum Publishers (1999).
  • •A review of molecular biology advances.
  • CASS CE, YOUNG JD, BALDWIN SA: Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem. Cell. Biol. (1998) 76 (0:761–770.
  • •A review of molecular biology advances.
  • GRIFFITH DA, JARVIS SM: Nucleoside and nucleobase transport systems of mammalian cells. Biochim. Biophys. Acta (1996) 1286(3):153–181.
  • •A review of functional studies.
  • CASS CE: Nucleoside transport. In: Drug Transport in Antimicrobial and AntiCancer Chemotherapy Georgopa-padakou NH (Ed.), Marcel Deker, New York, USA (1995):403–451.
  • •A review of functional studies.
  • MACKEY JR, MANI RS, SELNER M et al.: Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res. (1998) 58(19):4349–4357.
  • BALDWIN SA, MACKEY JR, CASS CE, YOUNG JD: Nucleo-side transporters: molecular biology and implications for therapeutic development. Mol. Med. Today (1999) 5 (5):216–224.
  • •A review of functional studies.
  • MANI RS, HAMMOND JR, MARJAN JM et al.: Demonstra-tion of equilibrative nucleoside transporters (hEND and hEN112) in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional reconsti-tution in proteoliposomes. J. Biol. Chem. (1998) 273(46)30818–30825.
  • PISONI RL, THOENE JG: Detection and characterization of a nucleoside transport system in human fibroblast lysosomes. J. Biol. Chem. (1989) 264 (0:4850–4856.
  • CAMINS A, JIMENEZ A, SUREDA FX et al.: Characteriza-tion of nitrobenzylthioinosine binding sites in the mitochondrial fraction of rat testis. Life Sci. (1996) 58 (0:753–759.
  • JIMENEZ A, PUBILL D, PALLAS M et al.: Further charac-terization of an adenosine transport system in the mitochondrial fraction of rat testis. Eur. j PharmacoL (2000) 398(1):31–39.
  • FLANAGAN SA, MECKLING-GILL KA: Characterization ofa novel Natdep en dent, guanosine-specific, nitrobenzylthioinosine-sensitive transporter in acute promyelocytic leukemia cells. J Biol. Chem. (1997) 272 (29):18026–18032.
  • WANG J, SCHANER ME, THOMASSEN S et al.: Functionaland molecular characteristics of Na(+)-dependent nucleoside transporters. Pharmacol. Res. (1997) 14(10:1524–1532.
  • HUANG QQ, YAO SY, RITZEL MW et al: Cloning andfunctional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J. Biol. Chem. (1994) 269 (27) :17757–17760.
  • YAO SY, NG AM, RITZEL MW et al.: Transport ofadenosine by recombinant purine-and pyrimidine-selective sodium/nucleoside cotransporters from rat jejunum expressed in Xenopus laevis oocytes. Mol. Pharmacol. (1996) 50 (6) :1529–1535.
  • CHE M, ORTIZ DF, ARIAS IM: Primary structure andfunctional expression of a cDNA encoding the bile canalicular, purine-specific Na(+)-nucleoside cotrans-porter. J Biol. Chem. (1995) 270(23):13596–13599.
  • RITZEL MW, YAO SY, HUANG MY et al: Molecular cloning and functional expression of cDNAs encoding a human Natnucleoside cotransporter (hCNT1). Am../ Physiol (1997) 272(2 Pt 1):C707–C714.
  • ••Molecular cloning of a human nucleoside transporter.
  • YAO SY, NG AM, MUZYKA WR et al: Molecular cloning and functional characterization of nitrobenzylthioi-n o sin e (NBMPR)-s en sitive (es) and NBMPR-in s en sitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. jBiol Chem. (1997) 272(45):28423–28430.
  • RITZEL MW, YAO SY, NG AM et al: Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Nat/nucleoside cotrans-porter (hCNT2) selective for purine nucleosides and uridine. Mol. Membr. Biol. (1998) 15(4):203–211.
  • ••Molecular cloning of a human nucleoside transporter.
  • GRIFFITHS M, BEAUMONT N, YAO SY et al: Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nature Med. (1997) 3(0:89–93.
  • ••Molecular cloning of a human nucleoside transporter.
  • GRIFFITHS M, YAO SY, ABIDI F et al: Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem. J. (1997) 328(Pt 3):739–743.
  • ••Molecular cloning of a human nucleoside transporter.
  • WANG J, SU SF, DRESSER MJ et al: Na(+)-dependent purine nucleoside transporter from human kidney: cloning and functional characterization. Am. J Physiol. (1997) 273(6 Pt 2):F1058–F1065.
  • ••Molecular cloning of a human nucleoside transporter.
  • CRAWFORD CR, PATEL DH, NAEVE C, BELT JA: Cloning of the human equilibrative, nitrobenzylmercap topu-rine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line. J. Biol. Chem. (1998) 273(9):5288-5293.
  • ••Molecular cloning of a human nucleoside transporter.
  • PAJOR AM: Sequence of a pyrimidine-selective Na+/nucleoside co transp or ter from pig kidney, pkCNT1. Biochim. Biophys. Acta (1998) 1415(0:266–269.
  • PATEL DH, CRAWFORD CR, NAEVE CW, BELT JA: Cloning, genomic organization and chromosomal localization of the gene encoding the murine sodium-dependent, purine-selective, concentrative nucleoside transporter (CNT2). Gene (2000) 242 (1-2):51–58.
  • HUANG QQ, HARVEY CM, PATERSON AR, CASS CE, YOUNG JD: Functional expression of Na(+)-dependent nucleoside transport systems of rat intestine in isolated oocytes of Xenopus laevis. Demonstration that rat jejunum expresses the purine-selective system Ni (cif) and a second, novel system N3 having broad specificity for purine and pyrimidine nucleosides. J Biol. Chem. (1993) 268 (27):20613–20619.
  • FELIPE A, VALDES R, SANTO B et al: Natdependentnucleoside transport in liver: two different isoforms from the same gene family are expressed in liver cells. Biochem. J. (1998) 330 (Pt 2):997–1001.
  • ANDERSON CM, XIONG W, YOUNG JD, CASS CE, PARKINSON FE: Demonstration of the existence of mRNAs encoding N1/cif and N2/cit sodium/nucleo-side cotransporters in rat brain. Brain Res. Mol. Brain Res. (1996) 42(2):358–361.
  • YAO SY, CASS CE, YOUNG JD: Transport of the antiviral nucleoside analogs 3t-azido-3t-deoxythymidine and 2', 3t-dideoxycytidine by a recombinant nucleoside transporter (rCNT) expressed in Xenopus laevis oocytes. Mol Pharmacol (1996) 50(2):388–393.
  • WANG J, GIACOMINI KM: Molecular determinants of substrate selectivity in Natdependent nucleoside transporters. J Biol. Chem. (1997) 272(46):28845–28848.
  • FANG X, PARKINSON FE, MOWLES DA, YOUNG JD, CASSCE: Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1 rat) by transient expression in cultured mammalian cells. Biochem. J. (1996) 317 (Pt 2):457–465.
  • LOEWEN SK, NG AM, YAO SY et al.: Identification ofamino acid residues responsible for the pyrimidine and purine nucleoside specificities of human concen-trative Na(+) nucleoside cotransporters hCNT1 and h CNT2 j Biol. Chem. (1999) 274(35):24475–24484.
  • WANG J, GIACOMINI KM: Serine 318 is essential for thepyrimidine selectivity of the N2 Natnucleoside transporter. J Biol. Chem. (1999) 274(02298–2302.
  • KWONG FY, DAVIES A, TSE CM et al.: Purification of thehuman erythrocyte nucleoside transporter by immunoaffinity chromatography. Biochem. J (1988) 255 (1):243–249.
  • BOLETI H, COE IR, BALDWIN SA, YOUNG JD, CASS CE: Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstra-tion of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells. Neuropharmacology (1997) 36 (9) :1167–1179.
  • COE IR, GRIFFITHS M, YOUNG JD, BALDWIN SA, CASS CE: Assignment of the human equilibrative nucleoside transporter (hENTI) to 6p21.1-p21.2. Genomics (1997) 45 (2):459–460.
  • SUNDARAM M, YAO SYM, NG AML et al: Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. J. Biol. Chem. (1998) 273 (34):21519–21525.
  • PATERSON AR, GATI WP, VIJAYALAKSHMI D et al: Inhibitor-sensitive, Na(+)-linked transport of nucleo-side analogs in leukemia cells from patients (meeting abstract). Proc. Ann. Meet. Am. Assoc. Cancer Res. (1993) 34 :A84.
  • BELT JA, MARINA NM, PHELPS DA, CRAWFORD CR: Nucleoside transport in normal and neoplastic cells. Adv. Enzyme Regul. (1993) 33:235–252.
  • BERENS RL, KRUG EC, MARR JJ: Biochemistry and Molecular Biology of Parasites. Marr JJ, Muller M (Eds.) Academic Press, Inc., New York, USA (1995):89–117.
  • VASUDEVAN G, CARTER NS, DREW ME et al.: Cloning of Leishmania nucleoside transporter genes by rescue of a transport-deficient mutant. Proc. Natl. Acad. ScL USA (1998) 95 (17):9873–9878.
  • CARTER NS, DREW ME, SANCHEZ M et al: Cloning of a novel inosine-guanosine transporter gene from Leishmania donovani by functional rescue of a transport-deficient mutant. J. Biol. Chem. (2000) 275:20935–20941.
  • MASER P, SUTTERLIN C, KRALLI A, KAMINSKY R: A nucleoside transporter from Trypanosoma brucei involved in drug resistance. Science (1999) 285 (5425):242–244.
  • SANCHEZ MA, ULLMAN B, LANDFEAR SM, CARTER NS: Cloning and functional expression of a gene encoding a P1 type nucleoside transporter from Trypanosoma brucei. J. Biol. Chem. (1999) 274(42):30244–30249.
  • SCHWAB JC, AFIFI AFIFI M, PIZZORNO G, HANDSCHU-MACHER RE, JOINER KA: Toxoplasma gondii tachyzoi-tes possess an unusual plasma membrane adenosine transporter. Mol. Biochem. Parasitol (1995) 70(1-2):59–69.
  • CHIANG CW, CARTER N, SULLIVAN WJ, JR. et al.: The adenosine transporter of Toxoplasmagondii. Identifi-cation By insertional mutagenesis, cloning and recombinant expression. J. Biol. Chem. (1999) 274 (49):35255–35261.
  • CARTER NS, BEN MAMOUN C, LIU W et al.: Isolation and functional characterization of the PfNT1 nucleoside transporter gene from Plasmodium falciparum. J. Biol Chem. (2000) 275 (14):10683–10691.
  • PARKER MD, HYDE RJ, YAO SY et al.: Identification of anucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy. Biochem. j (2000) 349 (Pt 1) :67–75.
  • RAO TV, VERMA RS, PRASAD R: Transport of purine, pyrimidine bases and nucleosides in Candida albicans, a pathogenic yeast. Biochem. Int. (1983) 6 (3) :409–417.
  • FASOLI MO AND KERRIDGE D: Uptake of pyrimidines and their derivatives into Candida glabrata and Candida albicans. J. Gen. Microbiol (1990) 136 (Pt 8):1475–1481.
  • FASOLI MO, KERRIDGE D, MORRIS PG, TOROSANTUCCI A: 19F nuclear magnetic resonance study of fluoropy-rimidine metabolism in strains of Candida glabrata with specific defects in pyrimidine metabolism. Antimicrob. Agents Chemother. (1990) 34 (10):1996–2006.
  • DETKE S: Cloning of the Candida albicans nucleoside transporter by complementation of nucleoside transport-deficient Saccharomyces. Yeast (1998) 14 (14):1257–1265.
  • GRENSON M: The utilization of exogenous pyrimidines and the recycling of uridine-5'-phosphate derivatives in Saccharomyces cerevisiae, as studied by means of mutants affected in pyrimidine uptake and metabo-lism. Eur. j Biochem. (1969) 11 (2):249–260.
  • JUND R, LACROUTE F: Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae. J. Bacteriol. (1970) 102 (3) :607–615.
  • NELISSEN B, MORDANT P, JONNIAUX JL, DE WACHTER R, GOFFEAU A: Phylogenetic classification of the major superfamily of membrane transport facilitators, as deduced from yeast genome sequencing. FEBS Lett. (1995) 377 (2):232–236.
  • NELISSEN B, DE WACHTER R, GOFFEAU A: Classification of all putative permeases and other membrane pluris-panners of the major facilitator superfamily encoded by the complete genome of Saccharomyces cerevisiae. FEMS Microbiol. Rev. (1997) 21(2):113–134.
  • WAGNER R, DE MONTIGNY J, DE WERGIFOSSE P, SOUCIET JL, POTIER S: The ORF YBID42 of Saccharo-myces cerevisiae encodes a uridine permease. FEMS Microbic)]. Lett. (1998) 159(0:69–75.
  • VICKERS MF, YAO SYM, BALDWIN SA, YOUNG JD, CASS CE: Nucleoside transporter proteins of Saccharo-myces cerevisiae: demonstration of a transporter (FUI1) with high uridine selectivity in plasma membranes and a transporter (FUN26) with broad nucleoside selectivity in intracellular membranes. J Biol. Chem. (2000) (In Press).
  • BARTON AB, KABACK DB: Molecular cloning of chromosome I DNA from Saccharomyces cerevisiae: analysis of the genes in the FUN38-MAKI. 6-SPO7 region. J. Bacteriol (1994) 176 (7) :1872–1880.
  • CRAIG JE, ZHANG Y, GALLAGHER MP: Cloning of thenupC gene of Escherichia coli encoding a nucleoside transport system and identification of an adjacent insertion element, IS 186. Mot. Microbio I. (1994) 1 1 (6):1159–1168.
  • WESTH HANSEN SE, JENSEN N, MUNCH-PETERSEN A: Studies on the sequence and structure of the Escheri-chia coli K-12 nupG gene, encoding a nucleoside-transport system. Eur.J. Biochem. (1987) 168 (2):385–391.
  • YAO SYM: Intestinal nucleoside and amino acid transport. In: Physiology. Edmonton, University of Alberta (1995)236.
  • MUNCH-PETERSEN A, JENSEN N: Analysis of the regula-tory region of the Escherichia coli nupG gene, encoding a nucleoside-transport protein. Eur. J. Biochem. (1990) 190(3):547–551.
  • MACKEY JR, BALDWIN SA, YOUNG JD, CASS CE: Nucleo-side transport and its significance for anticancer drug resistance. Drug Resist. Updates (1998) 1:310–324.
  • •A review of functional studies.
  • SCHANER ME, GERSTIN KM, WANG J, GIACOMINI KM: Mechanisms of transport of nucleosides and nucleo-side analogues in choroid plexus. Adv. Drug Deliv. Rev. (1999) 39(1-3):51–62.
  • ARONOW B, ULLMAN B: Thymidine incorporation in nucleoside transport-deficient lymphoma cells. j Biol Chem. (1985) 260(30):16274–16278.
  • CASS CE, KOLASSA N, UEHARA Y et al.: Absence ofbinding sites for the transport inhibitor nitrobenzyl-thioinosine on nucleoside transport-deficient mouse lymphoma cells. Biochim. Biophys. Acta (1981) 649 (3):769–777.
  • COHEN A, ULLMAN B, MARTIN DW, JR.: Characterizationof a mutant mouse lymphoma cell with deficient transport of purine and pyrimidine nucleosides. J Biol. Chem. (1979) 254(0:112–116.
  • ULLMAN B, COONS T, ROCKWELL S, MCCARTAN K: Genetic analysis of 2', 3t-dideoxycytidine incorpora-tion into cultured human Tlymphoblasts. J. Biol. Chem. (1988) 263 (25):12391–12396.
  • ULLMAN B: Dideoxycytidine metabolism in wild typeand mutant CEM cells deficient in nucleoside transport or deoxycytidine kinase. Adv. Exp. Med. Biol. (1989) 293B:415–20.
  • POLLERA CF, CERIBELLI A, CRECCO M, OLIVA C, CALABRESI F: Prolonged infusion gemcitabine: a clinical Phase I study at low-(300 mg/m2) and high-dose (875 mg/m2) levels. Invest. New Drugs (1997) 1 5 (2):115–121.
  • WANG J AND GIACOMINI KM: Characterization of a bioengineered chimeric Natnucleoside transporter. Mot. Pharmacol. (1999) 55(2):234–240.
  • MACKEY JR, YAO SY, SMITH KM et al.: Gemcitabinetransport in Xenopus oocytes expressing recombi-nant plasma membrane mammalian nucleoside transporters. j Natl. Cancer Inst. (1999) 91 (20:1876–1881.
  • SCHANER ME, WANG J, ZEVIN S, GERSTIN KM, GIACOMINI KM: Transient expression of a purine-selective nucleoside transporter (SPNTint) in a human cell line (HeI2.). Pharmacol. Res. (1997) 1 4 (10) :1316–1321.
  • CRAWFORD CR, CASS CE, YOUNG JD, BELT JA: Stable expression of a recombinant sodium-dependent, pyrimidine-selective nucleoside transporter (CNT1) in a transport-deficient mouse leukemia cell line. Biochem. Cell. Biol (1998) 76(5):843–851.
  • SCHANER ME, WANG J, ZHANG L et al.: Functional characterization of a human purine-selective, Natdependent nucleoside transporter (hSPNT1) in a mammalian expression system. J. Pharmacol Exp. Ther. (1999) 289(3):1487–1491.
  • WARD JL, SHERALI A, MO ZP, TSE CM: Kinetic and pharmacological properties of cloned human equili-brative nucleoside transporters, ENT! and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for g-uanosine and cytidine but a high affinity for inosine. j Biol. Chem. (2000) 275(12):8375–8381.
  • SEKLER I, KOPITO R, CASEY JR: High level expression, partial purification and functional reconstitution of the human AF1 anion exchanger in Saccharomyces cerevisiae. j Biol. Chem. (1995) 270(36):21028–21034.
  • RUETZ S, GROS P: Functional expression of P-glycoproteins in secretory vesicles. J Biol. Chem. (1994) 269(16):12277–12284.
  • VICKERS MF, MANI RS, SUNDARAM M et al.: Functionalproduction and reconstitution of the human equilibra-tive nucleoside transporter (hENT1) in Saccharo-myces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q). Biochem. J. (1999) 339 (Pt 0:21–32.
  • AUSUBEL FM, BRENT R, KINGSTON RE et al.: Current protocols in molecular biology. In: Current Protocols. Chanda VB (Ed.), John Wiley & Sons, Inc., New York, USA (1997).
  • HOGUE DL, ELLISON MJ, YOUNG JD, CASS CE: Identifica-tion of a novel membrane transporter associated with intracellular membranes by phenotypic complemen-tation in the yeast Saccharomyces cerevisiae. J. Biol. Chem. (1996) 271 (16):9801–9808.
  • HOGUE DL, ELLISON MJ, VICKERS M, CASS CE: Functional complementation of a membrane transport deficiency in Saccharomyces cerevisiae by recombinant ND4 fusion protein. Biochem. Biophys. Res. Commun. (1997) 238 (3):811–816.
  • GUITERREZ MM, BRETT CM, OTT RJ, HUI AC, GIACOMINI KM: Nucleoside transport in brush border membrane vesicles from human kidney. Biochem. Biophys. Acta (1992) 1105(0:1–9.
  • GUITERREZ MM, GIACOMINI KM: Substrate selectivity, potential sensitivity and stoichiometry of Na-nucle-oside transport in brush border membranes from human kidney. Biochem. Biophys. Acta (1993) 1149 (2) :202–208.
  • ANDERSON CM, BALDWIN SA, YOUNG JD, CASS CE, PARKINSON FE: Distribution of mRNA encoding a nitr Oben zyltioin o sine-insensitive nucleoside transporter (ENT2) in rat brain. Brain Res. Mol. Brain Res. (1999) 70(2):293–297.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.